12,750-share sale reported by CVNA insider (CVNA) via option exercise

Rhea-AI Filing Summary

CVNA Form 144 reports an intended sale of 12,750 common shares by exercise of stock options on 03/02/2026 for cash. The filing also discloses two prior 10b5-1 sales of 12,750 shares each on 02/02/2026 and 01/02/2026, with proceeds of $5,229,874.60 and $5,138,510.80, respectively.

Insights

Insider Transactions Analyst

Reported insider sales via option exercise and 10b5-1 plans, with proceeds disclosed.

The filing lists an intended sale of 12,750 common shares on 03/02/2026 arising from an exercise of stock options and identifies two prior 10b5-1 sales of 12,750 shares each on 02/02/2026 and 01/02/2026.

Proceeds for the prior sales are shown as $5,229,874.60 and $5,138,510.80. Timing and mechanism are explicit; cash treatment for the exercise is listed as cash. Subsequent filings may report settlement details or additional trades.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12750	4260540.00	142736197	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Exercise of Stock Options	Issuer			12750	03/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway Tempe AZ 85281	Common	02/02/2026	12750	5229874.60
10b5-1 Sales for MARK JENKINS 300 E. Rio Salado Parkway Tempe AZ 85281	Common	01/02/2026	12750	5138510.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CVNA Form 144 disclose about new sales?

The filing shows an intended sale of 12,750 common shares on 03/02/2026 resulting from an exercise of stock options and designated as a cash transaction.

What prior insider sales does the CVNA excerpt show?

It lists two prior 10b5-1 sales of 12,750 shares each on 02/02/2026 and 01/02/2026, recorded in the filing as transactions by the named plan participant.

How much proceeds were reported for the prior CVNA 10b5-1 sales?

The prior sales show proceeds of $5,229,874.60 (02/02/2026) and $5,138,510.80 (01/02/2026), as disclosed in the filing's sales table.

Who is identified in the filing related to the 10b5-1 sales?

The sales entries reference Mark Jenkins and list the 10b5-1 plan address; the filing names the plan participant for the two prior sales and includes transaction dates and amounts.